Barclays Initiates Coverage On Lumexa Imaging Holdings with Overweight Rating, Announces Price Target of $23

Benzinga · 01/05 16:51
Barclays initiates coverage on Lumexa Imaging Holdings (NASDAQ:LMRI) with a Overweight rating and announces Price Target of $23.